Acyclovir plus CMV immunoglobulin prophylaxis and early therapy with ganciclovir are effective and safe in CMV high-risk renal transplant pediatric recipients (Q47842996)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Acyclovir plus CMV immunoglobulin prophylaxis and early therapy with ganciclovir are effective and safe in CMV high-risk renal transplant pediatric recipients |
scientific article |
Statements
1 reference
Acyclovir plus CMV immunoglobulin prophylaxis and early therapy with ganciclovir are effective and safe in CMV high-risk renal transplant pediatric recipients (English)
1 reference
Ginevri F
1 reference
Losurdo G
1 reference
Fontana I
1 reference
Rabagliati AM
1 reference
Bonatto L
1 reference
Valente R
1 reference
Venzano P
1 reference
Nocera A
1 reference
Basile GC
1 reference
Valente U
1 reference
Gusmano R
1 reference
1 January 1998
1 reference
11 Suppl 1
1 reference
S130-4
1 reference